Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 10 | 2022 | 83 | 4.650 |
Why?
|
| Antibodies, Monoclonal, Humanized | 9 | 2022 | 219 | 1.930 |
Why?
|
| Inflammatory Bowel Diseases | 4 | 2022 | 103 | 1.710 |
Why?
|
| Adalimumab | 3 | 2021 | 36 | 1.090 |
Why?
|
| Crohn Disease | 4 | 2022 | 109 | 0.990 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2022 | 7 | 0.830 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 157 | 0.820 |
Why?
|
| Feces | 1 | 2022 | 96 | 0.790 |
Why?
|
| Colon | 1 | 2021 | 137 | 0.690 |
Why?
|
| Wound Healing | 1 | 2021 | 176 | 0.690 |
Why?
|
| Gastrointestinal Agents | 4 | 2022 | 29 | 0.620 |
Why?
|
| Mothers | 1 | 2021 | 261 | 0.590 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2015 | 4 | 0.520 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2015 | 86 | 0.480 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2015 | 117 | 0.480 |
Why?
|
| Remission Induction | 3 | 2022 | 137 | 0.430 |
Why?
|
| Clinical Trials as Topic | 2 | 2022 | 436 | 0.310 |
Why?
|
| Treatment Outcome | 4 | 2022 | 5134 | 0.300 |
Why?
|
| Colonoscopy | 2 | 2021 | 103 | 0.290 |
Why?
|
| Humans | 14 | 2022 | 59188 | 0.260 |
Why?
|
| Injections, Subcutaneous | 2 | 2021 | 70 | 0.230 |
Why?
|
| Infusions, Intravenous | 2 | 2021 | 170 | 0.220 |
Why?
|
| Infant | 2 | 2021 | 1527 | 0.220 |
Why?
|
| Double-Blind Method | 2 | 2021 | 684 | 0.200 |
Why?
|
| Child | 4 | 2022 | 4297 | 0.200 |
Why?
|
| Supervised Machine Learning | 1 | 2021 | 3 | 0.200 |
Why?
|
| Lactation | 1 | 2021 | 70 | 0.180 |
Why?
|
| Bias | 1 | 2020 | 106 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 1 | 2020 | 196 | 0.170 |
Why?
|
| Infliximab | 1 | 2020 | 54 | 0.170 |
Why?
|
| Milk, Human | 1 | 2021 | 94 | 0.170 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 1024 | 0.170 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 150 | 0.160 |
Why?
|
| Prognosis | 1 | 2022 | 1564 | 0.150 |
Why?
|
| Research Design | 1 | 2020 | 565 | 0.140 |
Why?
|
| Biomarkers | 1 | 2022 | 1203 | 0.140 |
Why?
|
| Capsule Endoscopy | 1 | 2017 | 38 | 0.140 |
Why?
|
| Time Factors | 2 | 2021 | 3561 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 73 | 0.130 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 1446 | 0.130 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2015 | 4 | 0.130 |
Why?
|
| Inflammation | 1 | 2022 | 1100 | 0.130 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 39 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2460 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 349 | 0.120 |
Why?
|
| Cathartics | 1 | 2014 | 11 | 0.120 |
Why?
|
| Female | 5 | 2021 | 30768 | 0.110 |
Why?
|
| Recurrence | 1 | 2015 | 576 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2014 | 174 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2021 | 3093 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2015 | 1836 | 0.110 |
Why?
|
| Middle Aged | 4 | 2021 | 16209 | 0.100 |
Why?
|
| Adult | 4 | 2021 | 15709 | 0.100 |
Why?
|
| Infant, Newborn | 1 | 2015 | 1311 | 0.090 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 711 | 0.080 |
Why?
|
| Male | 4 | 2021 | 27447 | 0.080 |
Why?
|
| Adolescent | 2 | 2015 | 5912 | 0.070 |
Why?
|
| Gastroenterology | 2 | 2017 | 53 | 0.060 |
Why?
|
| Pediatrics | 2 | 2017 | 266 | 0.050 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2020 | 11 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 281 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2020 | 115 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2019 | 18 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 151 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 433 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1056 | 0.040 |
Why?
|
| Contraindications, Procedure | 1 | 2017 | 3 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 837 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 664 | 0.040 |
Why?
|
| North America | 1 | 2017 | 114 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2017 | 60 | 0.030 |
Why?
|
| Cytokines | 1 | 2020 | 909 | 0.030 |
Why?
|
| Informed Consent | 1 | 2017 | 133 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 2323 | 0.030 |
Why?
|
| Laxatives | 1 | 2014 | 5 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2434 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 1108 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 4314 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 5960 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 13272 | 0.010 |
Why?
|